<DOC>
	<DOCNO>NCT00829777</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy intravenous 6β-Naltrexol administer opiate dependent subject</brief_summary>
	<brief_title>Safety Study Intravenous 6β-Naltrexol ( AIKO-150 ) Opioid-Dependent Subjects</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Opiate dependent male females age 2145 stable dos methadone Fluent English speaker Willing able give write consent Pregnancy lactation FOR MORE DETAILS CONTACT THE RESEARCH CLINIC .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Naloxone</keyword>
	<keyword>6β-Naltrexol</keyword>
	<keyword>Opioid-dependent</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>peripheral effect withdrawal</keyword>
	<keyword>central effect withdrawal</keyword>
</DOC>